Schedule 13G ownership disclosure

BioAge Labs Inc

Common Stock, par value $0.00001 per share · CUSIP: 09077V100

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.

    Shares: 1,310,589.00 · Class: 3.7%

  • Peter Kolchinsky

    Shares: 1,310,589.00 · Class: 3.7%

  • Rajeev Shah

    Shares: 1,310,589.00 · Class: 3.7%

  • RA Capital Healthcare Fund, L.P.

    Shares: 982,942.00 · Class: 2.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-004265
Form type
SCHEDULE 13G/A
Filer
BioAge Labs, Inc.
CIK
CIK 1709941
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub